Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

What's new

New brain scan may pinpoint early progression of Alzheimer’s disease

The New therapeutics in Alzheimer's Disease (NTAD) study, supported by Dementias Platform UK (DPUK), is testing new brain scans that are revealing early changes in the brain that are a signature of Alzheimer’s disease. These markers for the disease will be used to test whether experimental treatments can delay, or even prevent, the progression of the disease.

DPUK brain imaging: harmonisation study launch

The first participant in the final stage to prepare DPUK’s scanners for multi-site dementia research comes in for their brain scan today

DPUK researchers take up international opportunities

Two early career scientists have used their DPUK funding to pursue international dementia research.

DPUK researchers featured by ‘women in science’ illustrator

Three of DPUK’s researchers are the subject of drawings by the science illustrator Nina Chhita this month.

Dates for your diary

Funding call: UK-Japan Regenerative Medicine and Stem Cell Research Initiative

Thursday, 20 February 2020

A joint call between MRC and the Japan Agency for Medical Research and Development (AMED) for research proposals focused on Regenerative Medicine and Stem Cell Research.

Population health conference at Cardiff University

Tuesday, 10 March 2020

DPUK Director, John Gallacher, will be giving the keynote address on Dementias Platform UK.

Cognitive neuroscience society annual meeting

Saturday, 14 March 2020 to Tuesday, 17 March 2020